In search of specific inhibitors of retrovirus replication.
E
E
De Clercq
J
J
Balzarini
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000382:microbiology; D000578:Amidines / Q000494:pharmacology; D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D002472:Cell Transformation, Viral / Q000187:drug effects; D004396:Coloring Agents / Q000037:antagonists & inhibitors; D004261:DNA Replication / Q000187:drug effects; D017977:Deltaretrovirus / Q000187:drug effects; D005912:Gliotoxin / Q000494:pharmacology; D006801:Humans; D007231:Infant, Newborn; D007372:Interferons / Q000627:therapeutic use; D051379:Mice; D008979:Moloney murine leukemia virus / Q000187:drug effects / Q000201:enzymology; D008980:Moloney murine sarcoma virus / Q000187:drug effects / Q000502:physiology; D012190:Retroviridae / Q000187:drug effects* / Q000201:enzymology / Q000254:growth & development; D018894:Reverse Transcriptase Inhibitors; D013329:Structure-Activity Relationship; D013498:Suramin / Q000494:pharmacology / Q000627:therapeutic use; D013698:Templates, Genetic; D014779:Virus Replication / Q000187:drug effects*
D000578:Amidines; D000998:Antiviral Agents; D004396:Coloring Agents; D018894:Reverse Transcriptase Inhibitors; D013498:Suramin; D005912:Gliotoxin; D007372:Interferons